OTCMKTS:NDVAF Indiva (NDVAF) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NDVAF Stock Alerts $0.05 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.03▼$0.0752-Week Range$0.01▼$0.09Volume5,000 shsAverage Volume38,185 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Indiva alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Indiva Stock (OTCMKTS:NDVAF)Indiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.Read More NDVAF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NDVAF Stock News HeadlinesMarch 4, 2024 | finance.yahoo.comIndiva Announces Closing of the First Tranche of Life Offering & Provides Update on Previously Announced Private PlacementFebruary 28, 2024 | finance.yahoo.comIndiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 MillionApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.January 6, 2024 | markets.businessinsider.comIndiva’s Strong Sales and Market Share Gains Prompt Buy Rating and Raised Price TargetJanuary 4, 2024 | finance.yahoo.comIndiva Provides Corporate Update Including Improved Fourth Quarter Revenue GuidanceDecember 19, 2023 | investing.comIndiva (NDVA) Earnings Dates & ReportsNovember 20, 2023 | markets.businessinsider.comWhat Wall Street expects from Indiva's earningsNovember 9, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd flat on Thursday (NDVA)April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.October 6, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd up on Thursday (NDVA)August 29, 2023 | markets.businessinsider.comEchelon Wealth Partners Sticks to Its Hold Rating for Indiva (NDVAF)August 29, 2023 | benzinga.comCanadian Weed Edibles Producer's Q2 Financial Results Show Drop In Revenue & Gross Profit, Here's WhyAugust 29, 2023 | seekingalpha.comIndiva GAAP EPS of -C$0.01, revenue of C$7.5MAugust 1, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd flat on Monday (NDVA)June 22, 2023 | benzinga.comSNDL Lowers Its Stake In Indiva To 8.57%June 9, 2023 | finance.yahoo.comSNDL FILES EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103May 16, 2023 | markets.businessinsider.comEchelon Wealth Partners Sticks to Their Hold Rating for Indiva (NDVAF)May 3, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd flat on Wednesday (NDVA)May 3, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd flat on Tuesday (NDVA)May 1, 2023 | finance.yahoo.comIndiva Limited (NDVAF) Stock Historical Prices & Data - Yahoo FinanceApril 27, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd down on Thursday (NDVA)April 21, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd flat on Friday (NDVA)April 20, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd up on Wednesday (NDVA)April 19, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd down on Tuesday (NDVA)April 18, 2023 | markets.businessinsider.comIndiva FY22 Revenue Grows 6.8% To A Record $25.7M, Provides OutlookApril 17, 2023 | theglobeandmail.comClosing Bell: Indiva Ltd down on Monday (NDVA)April 17, 2023 | markets.businessinsider.comIndiva is about to announce its earnings — here's what to expectSee More Headlines Receive NDVAF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Next Earnings (Estimated)5/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:NDVAF CUSIPN/A CIKN/A Webwww.indiva.com Phone(888) 649-6686FaxN/AEmployees95Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Carmine MarottaCo-Founder, President, CEO & DirectorMs. Jennifer WelshChief Financial OfficerMr. Robert William CarseChief Operating OfficerMr. Sung Koo KangChief Commercial OfficerMr. Pete YoungCo-founderMark HaynesVice President of SalesMr. Mitchell SternVice President of MarketingMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors NDVAF Stock Analysis - Frequently Asked Questions How have NDVAF shares performed in 2024? Indiva's stock was trading at $0.0640 at the beginning of the year. Since then, NDVAF stock has decreased by 28.0% and is now trading at $0.0461. View the best growth stocks for 2024 here. When is Indiva's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our NDVAF earnings forecast. How do I buy shares of Indiva? Shares of NDVAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NDVAF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indiva Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
